Records containing: Ovarian Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-03-12Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
-
CLINICAL_TRIALS study record update · 2017-12-06Psychological Changes in Cancer Patients Receiving a Biobehavioral Intervention: A Program Evaluation
-
CLINICAL_TRIALS study record update · 2017-08-29Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis
-
CLINICAL_TRIALS study record update · 2017-08-18Phase I Study Evaluating Indomethacin in Combination With Platinum-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2017-05-15A Pilot Study of AZD9150, a STAT3 Antisense Oligonucleotide in Malignant Ascites
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-05-15Phase II, Open-Label, Study of CAELYX and Carboplatin Intermediate Platinum-Sensitive (6-12 Months Treatment-free Interval) Relapsed Epithelial Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2017-04-14Randomized Phase 2 Trial Investigating Liposomal Doxorubicin With or Without Anti-Platelet Derived Growth Factor Receptor-Alpha (PDGFRα) Monoclonal Antibody IMC-3G3 in Patients With Platinum-Refractory or Platinum-Resistant Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2017-04-10A Phase I/II, Open-Label, Non-Randomized, Pilot Study of Weekly Paclitaxel, Every Four-week Carboplatin and Oral Vorinostat for Patients Newly Diagnosed With Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2017-03-20Self-Administered Guided Imagery in the Perioperative Period to Reduce Postoperative Distress in Gynecologic Oncology Patients: A Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2016-09-30Phase I Trial of Intraperitoneal ²¹²Pb-TCMC-Trastuzumab for HER-2 Expressing Malignancy
-
CLINICAL_TRIALS study record update · 2016-08-31Feasibility Study of Neoadjuvant Chemotherapy Followed by Interval Cytoreductive Surgery for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: JCOG0206
-
CLINICAL_TRIALS study record update · 2016-08-17ClinicalTrials.gov study NCT02869568
-
CLINICAL_TRIALS study record update · 2016-08-10Predictive Factors and Pharmacokinetics of Intra-peritoneal Chemotherapy
-
CLINICAL_TRIALS study record update · 2016-06-24A PHASE 1, DOSE ESCALATION STUDY OF PF-06263507 IN PATIENTS WITH ADVANCED SOLID TUMORS
-
CLINICAL_TRIALS study record update · 2016-06-22Improving Quality of Care for Patients With Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2016-06-03A Phase II, Open-Label, Randomised, Comparative, International Multicentre Study to Assess the Safety and Efficacy of Different Doses of AZD2281 Given Orally Twice Daily Versus Intravenous Liposomal Doxorubicin Given Monthly in Patients With Advanced BRCA1- or BRCA2-Associated Ovarian Cancer Who Have Failed Previous Platinum-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2016-03-16MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
-
CLINICAL_TRIALS study record update · 2016-02-29Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
-
CLINICAL_TRIALS study record update · 2016-02-26A Phase II Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
-
CLINICAL_TRIALS study record update · 2016-01-20Ovarian Cancer Early Detection Screening Program
-
CLINICAL_TRIALS study record update · 2016-01-12A Randomized, Double-blind, Placebo Controlled, Multi-center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked ( < 1 cm ) Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-12-31Randomized, Multicenter, Prospective Two-arm, Open-label Phase II Study to Investigate the Efficacy and Safety of Two ZK219477 i.v. Infusions (3-hour Infusion of 16mg/m2 Versus 0.5-hour Infusion of 16 mg/m2) in Patients With Recurrent Ovarian Cancer Progressing During, or Within 6 Months of the End of Platinum-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2015-12-15A Phase I Study of Two Different Doses of the Subcutaneous Administration of an Immunotherapeutic Vaccine, DPX-0907 in Advanced Stage Patients With Ovarian, Breast or Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-12-01A Multicenter Open Label Phase II Study of the Efficacy and Safety of AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) as Second Line Therapy in Patients With Recurrent Platinum Sensitive Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-28Contrast Enhanced Diffusion-weighted Magnetic Resonance Imaging for Detection of Pathologic Lymph Nodes in Ovarian Cancer - a Feasibility Study.